As COVID-19 cases and hospitalizations rise in the U.S., an expert is warning of a potential "viral blizzard" that could sweep the nation in a matter of weeks.
Experts report that recent updated findings of health complications in recipients of the Johnson & Johnson vaccine make it the least preferred vaccine.
Pfizer has released their latest findings on the efficacy of Paxlovid, an oral antiviral therapy designed to reduce hospitalizations or death from COVID-19.
The United States is experiencing a COVID-19 surge, with new cases exceeding an average of 100,000 per day. Here's what the former CDC director says we can do.
British drugmaker GlaxoSmithKline and VIR Biotechnology have produced a monoclonal antibody treatment that early data shows is effective against Omicron.
We have known from the start that the Omicron variant is likely to be very contagious, but that is about all we know with a reasonable degree of certainty.
According to recent data from Johns Hopkins University, the United States is averaging 100,000 new COVID-19 cases per day, the highest level in 2 months.
While protective antibodies can be found in those previously infected with COVID-19, the CDC emphasizes that levels of natural immunity decrease over time.
Longtime Republican leader Bob Dole passed away at 98. Though no official cause of death was stated, the former senator was diagnosed with lung cancer in 2021.
With the first case of the Omicron COVID-19 variant having been detected in California (via CNN), health experts now anticipate an inevitable spread in the U.S.
With the emergence of the first Omicron COVID-19 variant case in the U.S., the CDC continues to stress the importance of protection through vaccination.
Dr. Anthony Fauci told PBS NewsHour that the Omicron variant may be much more transmissible, but that current vaccines would likely offer some protection.